Thyroid hormone and angiogenesis (Q37625363)

21 August 2017

1 reference

title

Thyroid hormone and angiogenesis (English)

1 reference

21 August 2017

1 reference

Mary K Luidens

1

1 reference

21 August 2017

Shaker A Mousa

2

1 reference

21 August 2017

Faith B Davis

3

1 reference

21 August 2017

Hung-Yun Lin

4

1 reference

21 August 2017

Paul J Davis

5

1 reference

21 August 2017

publication date

30 October 2009

1 reference

21 August 2017

published in

Vascular Pharmacology

1 reference

21 August 2017

volume

52

1 reference

21 August 2017

issue

3-4

1 reference

21 August 2017

page(s)

142-145

1 reference

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Current insights on the biology and clinical aspects of VEGF regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Hypoxia-inducible factor-1alpha induces the coronary collaterals for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

The efficacy of a 'master switch gene' HIF-1alpha in a porcine model of chronic myocardial ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Rapid inhibition of thyroxine-induced bone resorption in the rat by an orally active vitronectin receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Membrane-initiated actions of estrogen on the endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Thyroid hormone analog, diiodothyropropionic acid (DITPA), exerts beneficial effects on chamber and cellular remodeling in cardiomyopathic hamsters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Thyroid hormone receptor-beta is associated with coronary angiogenesis during pathological cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Endothelium-targeted overexpression of constitutively active FGF receptor induces cardioprotection in mice myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Vascular actions of estrogens: functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor beta through the phosphatidylinositol 3-kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

VEGF-A and the induction of pathological angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Effects of thyroidectomy, T4, and DITPA replacement on brain blood vessel density in adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Disparate effects of thyroid hormone on actions of epidermal growth factor and transforming growth factor-alpha are mediated by 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Triiodothyronine increases calcium loss in a bed rest antigravity model for space flight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Coordinated capillary and myocardial growth in response to thyroxine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

The dynamic roles of angiopoietins in tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

Growth factor activation in myocardial vascularization: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2009.10.007

1 reference

21 August 2017

1 reference